Literature DB >> 19927548

Bradykinin receptor 2 antagonist (icatibant) for hereditary angioedema type III attacks.

Laurence Bouillet, Isabelle Boccon-Gibod, Denise Ponard, Christian Drouet, Jean Yves Cesbron, Chantal Dumestre-Perard, Nicole Monnier, Joel Lunardi, Christian Massot, Anne Gompel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19927548     DOI： 10.1016/S1081-1206(10)60369-9

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN： 1081-1206            Impact factor:   6.347


× No keyword cloud information.
  19 in total

Review 1.  Wolf in the sheep's clothing: intestinal angioedema mimicking infectious colitis.

Authors:  Asif Mehmood; Hafez Mohammad Ammar Abdullah; Faisal Inayat; Waqas Ullah
Journal:  BMJ Case Rep       Date:  2018-12-13

2.  One hypovolaemic shock…two kinin pathway abnormalities.

Authors:  Céline Guichon; Bernard Floccard; Brigitte Coppéré; Etienne Hautin; Florence Bagès-Limoges; Olivier Rouvière; Nicole Monnier; Christian Drouet; Bernard Allaouchiche
Journal:  Intensive Care Med       Date:  2011-04-12       Impact factor: 17.440

3.  Deficiency of plasminogen activator inhibitor 2 in plasma of patients with hereditary angioedema with normal C1 inhibitor levels.

Authors:  Kusumam Joseph; Baby G Tholanikunnel; Bethany Wolf; Konrad Bork; Allen P Kaplan
Journal:  J Allergy Clin Immunol       Date:  2015-09-26       Impact factor: 10.793

4.  Safety and efficacy of icatibant self-administration for acute hereditary angioedema.

Authors:  I Boccon-Gibod; L Bouillet
Journal:  Clin Exp Immunol       Date:  2012-06       Impact factor: 4.330

5.  Factor XII mutations, estrogen-dependent inherited angioedema, and related conditions.

Authors:  Karen E Binkley
Journal:  Allergy Asthma Clin Immunol       Date:  2010-07-28       Impact factor: 3.406

6.  2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema.

Authors:  Tom Bowen; Marco Cicardi; Henriette Farkas; Konrad Bork; Hilary J Longhurst; Bruce Zuraw; Emel Aygoeren-Pürsün; Timothy Craig; Karen Binkley; Jacques Hebert; Bruce Ritchie; Laurence Bouillet; Stephen Betschel; Della Cogar; John Dean; Ramachand Devaraj; Azza Hamed; Palinder Kamra; Paul K Keith; Gina Lacuesta; Eric Leith; Harriet Lyons; Sean Mace; Barbara Mako; Doris Neurath; Man-Chiu Poon; Georges-Etienne Rivard; Robert Schellenberg; Dereth Rowan; Anne Rowe; Donald Stark; Smeeksha Sur; Ellie Tsai; Richard Warrington; Susan Waserman; Rohan Ameratunga; Jonathan Bernstein; Janne Björkander; Kristylea Brosz; John Brosz; Anette Bygum; Teresa Caballero; Mike Frank; George Fust; George Harmat; Amin Kanani; Wolfhart Kreuz; Marcel Levi; Henry Li; Inmaculada Martinez-Saguer; Dumitru Moldovan; Istvan Nagy; Erik W Nielsen; Patrik Nordenfelt; Avner Reshef; Eva Rusicke; Sarah Smith-Foltz; Peter Späth; Lilian Varga; Zhi Yu Xiang
Journal:  Allergy Asthma Clin Immunol       Date:  2010-07-28       Impact factor: 3.406

Review 7.  Genetics of Hereditary Angioedema Revisited.

Authors:  Anastasios E Germenis; Matthaios Speletas
Journal:  Clin Rev Allergy Immunol       Date:  2016-10       Impact factor: 8.667

Review 8.  Angioedema with normal laboratory values: the next step.

Authors:  Janelle Sher; Mark Davis-Lorton
Journal:  Curr Allergy Asthma Rep       Date:  2013-10       Impact factor: 4.806

9.  An evidence-based review of the potential role of icatibant in the treatment of acute attacks in hereditary angioedema type I and II.

Authors:  Bernard Floccard; Etienne Hautin; Laurence Bouillet; Brigitte Coppere; Bernard Allaouchiche
Journal:  Core Evid       Date:  2012-09-27

10.  In pursuit of excellence: an integrated care pathway for C1 inhibitor deficiency.

Authors:  A L Manson; A Price; J Dempster; P Clinton-Tarestad; C Greening; R Enti; S Hill; S Grigoriadou; M S Buckland; H J Longhurst
Journal:  Clin Exp Immunol       Date:  2013-07       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.